Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 35

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Anatomy of Mdm2 and Mdm4 in evolution

Tan, Ban Xiong, Liew, Hoe Peng, Chua, Joy S., Ghadessy, Farid J., Tan, Yaw Sing, Lane, David P., Coffill, Cynthia R. · 2017 · Journal of Molecular Cell Biology

Abstract

Mouse double minute (Mdm) genes span an evolutionary timeframe from the ancient eukaryotic placozoa Trichoplax adhaerens to Homo sapiens, implying a significant and possibly conserved cellular role throughout history. Maintenance of DNA integrity and response to DNA damage involve many key regulatory pathways, including precise control over the tumour suppressor protein p53. In most vertebrates, degradation of p53 through proteasomal targeting is primarily mediated by heterodimers of Mdm2 and the Mdm2-related protein Mdm4 (also known as MdmX). Both Mdm2 and Mdm4 have p53-binding regions, acidic domains, zinc fingers, and C-terminal RING domains that are conserved throughout evolution. Vertebrates typically have both Mdm2 and Mdm4 genes, while analyses of sequenced genomes of invertebrate species have identified single Mdm genes, suggesting that a duplication event occurred prior to emergence of jawless vertebrates about 550-440 million years ago. The functional relationship between Mdm and p53 in T. adhaerens, an organism that has existed for 1 billion years, implies that these two proteins have evolved together to maintain a conserved and regulated function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjx002

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 92

  1. Bennett-Lovsey, 2002, The SWIB and the MDM2 domains are homologous and share a common fold, Bioinformatics, 18, 626, 10.1093/bioinformatics/18.4.626 · DOI
  2. Bernardi, 2004, PML regulates p53 stability by sequestering Mdm2 to the nucleolus, Nat. Cell Biol., 6, 665, 10.1038/ncb1147 · DOI · Paper page
  3. Bista, 2013, MDMX contains an autoinhibitory sequence element, Proc. Natl Acad. Sci. USA, 110, 17814, 10.1073/pnas.1317398110 · DOI
  4. Blackford, 2009, Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation, J. Virol., 83, 4000, 10.1128/JVI.02417-08 · DOI
  5. Brown, 2013, Stapled peptides with improved potency and specificity that activate p53, ACS Chem. Biol., 8, 506, 10.1021/cb3005148 · DOI · Paper page
  6. Bursać, 2012, Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress, Proc. Natl Acad. Sci. USA, 109, 20467, 10.1073/pnas.1218535109 · DOI · Paper page
  7. Cahilly-Snyder, 1987, Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line, Somat. Cell Mol. Genet., 13, 235, 10.1007/BF01535205 · DOI · Paper page
  8. Chakraborty, 2015, Corp regulates p53 in Drosophila melanogaster via a negative feedback loop, PLoS Genet., 11, e1005400, 10.1371/journal.pgen.1005400 · DOI
  9. Chang, 2013, Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy, Proc. Natl Acad. Sci. USA, 110, E3445, 10.1073/pnas.1303002110 · DOI · Paper page
  10. Chao, 2015, Mechanisms of p53 degradation, Clin. Chim. Acta, 438, 139, 10.1016/j.cca.2014.08.015 · DOI
  11. Chemes, 2015, Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions, Curr. Opin. Struct. Biol., 32, 91, 10.1016/j.sbi.2015.03.004 · DOI
  12. Chène, 2004, Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface, Mol. Cancer Res., 2, 20, 10.1158/1541-7786.20.2.1 · DOI
  13. Cheng, 2011, The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity, J. Virol., 85, 765, 10.1128/JVI.01890-10 · DOI
  14. Chua, 2015, Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish, Oncogene, 34, 5933, 10.1038/onc.2015.57 · DOI
  15. Coffill, 2016, The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans, Genes Dev., 30, 281, 10.1101/gad.274118.115 · DOI · Paper page
  16. Dolezelova, 2012, Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability, FEBS Lett., 586, 2225, 10.1016/j.febslet.2012.05.034 · DOI
  17. Donati, 2013, 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint, Cell Rep., 4, 87, 10.1016/j.celrep.2013.05.045 · DOI · Paper page
  18. Fakharzadeh, 1991, Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line, EMBO J., 10, 1565, 10.1002/j.1460-2075.1991.tb07676.x · DOI · Paper page
  19. Fei, 2003, P53 and radiation responses, Oncogene, 22, 5774, 10.1038/sj.onc.1206677 · DOI · Paper page
  20. Galli, 2010, MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation, J. Cell Sci., 123, 2423, 10.1242/jcs.061010 · DOI
  21. Grand, 1999, Definition of a major p53 binding site on Ad2E1B58K protein and a possible nuclear localization signal on the Ad12E1B54K protein, Oncogene, 18, 955, 10.1038/sj.onc.1202358 · doi:10.1038/sj.onc.1202358
  22. Grönroos, 2004, YY1 inhibits the activation of the p53 tumor suppressor in response to gienotoxic stress, Proc. Natl Acad. Sci. USA, 101, 12165, 10.1073/pnas.0402283101 · DOI · Paper page
  23. Gu, 2002, Mutual dependence of MDM2 and MDMX in their functional inactivation of p53, J. Biol. Chem., 277, 19251, 10.1074/jbc.C200150200 · DOI · Paper page
  24. Guo, 2013, Ionizing radiation induces a dramatic persistence of p53 protein accumulation and DNA damage signaling in mutant p53 zebrafish, Oncogene, 32, 4009, 10.1038/onc.2012.409 · DOI
  25. Gustin, 2011, Viral takeover of the host ubiquitin system, Front. Microbiol., 2, 161, 10.3389/fmicb.2011.00161 · DOI
  26. Han, 2007, HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target, Mod. Pathol., 20, 54, 10.1038/modpathol.3800727 · DOI
  27. Harada, 2002, Analysis of the adenovirus E1B-55 K-anchored proteome reveals its link to ubiquitination machinery, J. Virol., 76, 9194, 10.1128/JVI.76.18.9194-9206.2002 · DOI · Paper page
  28. Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
  29. He, 2016, Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop, Oncotarget, 7, 16217, 10.18632/oncotarget.7479 · DOI
  30. Horn, 2008, Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway, Oncogene, 27, 5774, 10.1038/onc.2008.189 · DOI
  31. Iyappan, 2010, Turning the RING domain protein MdmX into an active ubiquitin-protein ligase, J. Biol. Chem., 285, 33065, 10.1074/jbc.M110.115113 · DOI · Paper page
  32. Ji, 2013, In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide, J. Am. Chem. Soc., 135, 11623, 10.1021/ja405108p · DOI · Paper page
  33. Jin, 2006, 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation, EMBO J., 25, 1207, 10.1038/sj.emboj.7601010 · DOI
  34. Jones, 1998, Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis, Proc. Natl Acad. Sci. USA, 95, 15608, 10.1073/pnas.95.26.15608 · DOI · Paper page
  35. Kao, 1990, Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55 K proteins, Virology, 179, 806, 10.1016/0042-6822(90)90148-K · DOI · Paper page
  36. Koblish, 2006, Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo, Mol. Cancer Ther., 5, 160, 10.1158/1535-7163.MCT-05-0199 · DOI · Paper page
  37. Koster, 2011, Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway, Cell Death Dis., 2, e148, 10.1038/cddis.2011.33 · DOI
  38. Kress, 1979, Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum, J. Virol., 31, 472, 10.1128/jvi.31.2.472-483.1979 · DOI · Paper page
  39. Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
  40. Lakoma, 2015, The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma, Cell Death Discov., 1, 15026, 10.1038/cddiscovery.2015.26 · DOI
  41. Lane, 2010, The Mdm2 and p53 genes are conserved in the Arachnids, Cell Cycle, 9, 748, 10.4161/cc.9.4.10616 · DOI
  42. Lane, 2010, Mdm2 and p53 are highly conserved from placozoans to man, Cell Cycle, 9, 540, 10.4161/cc.9.3.10516 · DOI
  43. Lane, 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, 261, 10.1038/278261a0 · DOI · Paper page
  44. Lane, 2012, Mdm2 in evolution, Genes Cancer, 3, 320, 10.1177/1947601912458285 · DOI
  45. Leonova, 2013, p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs, Proc. Natl Acad. Sci. USA, 110, E89, 10.1073/pnas.1216922110 · DOI · Paper page
  46. Leslie, 2015, The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization, J. Biol. Chem., 290, 12941, 10.1074/jbc.M115.644435 · DOI
  47. Levine, 2016, P53 and the defenses against genome instability caused by transposons and repetitive elements, Bioessays, 38, 508, 10.1002/bies.201600031 · DOI
  48. Li, 2013, Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy, Clin. Cancer Res., 19, 34, 10.1158/1078-0432.CCR-12-0053 · DOI · Paper page
  49. Li, 2016, MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome, Sci. Transl. Med., 8, 336ra61, 10.1126/scitranslmed.aad9370 · DOI
  50. Lin, 1994, Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein, Genes Dev., 8, 1235, 10.1101/gad.8.10.1235 · DOI · Paper page
  51. Linke, 2008, Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans, Cell Death Differ., 15, 841, 10.1038/sj.cdd.4402309 · DOI · Paper page
  52. Linzer, 1979, Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9 · DOI · Paper page
  53. Liu, 2011, p53, oxidative stress, and aging, Antioxid. Redox Signal., 15, 1669, 10.1089/ars.2010.3644 · DOI · Paper page
  54. Liu, 2016, Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis, Oncogene
  55. Lunardi, 2010, A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network, Proc. Natl Acad. Sci. USA, 107, 6322, 10.1073/pnas.1002447107 · DOI
  56. Macias, 2010, An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction, Cancer Cell, 18, 231, 10.1016/j.ccr.2010.08.007 · DOI · Paper page
  57. Mehta, 2013, Evidence for at least six Hox clusters in the Japanese lamprey (Lethenteron japonicum), Proc. Natl Acad. Sci. USA, 110, 16044, 10.1073/pnas.1315760110 · DOI · Paper page
  58. Miciak, 2016, Long story short: p53 mediates innate immunity, Biochim. Biophys. Acta, 1865, 220
  59. Migliorini, 2002, Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation, J. Biol. Chem., 277, 7318, 10.1074/jbc.M108795200 · DOI
  60. Moll, 2004, p63 and p73: roles in development and tumor formation, Mol. Cancer Res., 2, 371, 10.1158/1541-7786.371.2.7 · DOI · Paper page
  61. Momand, 1998, The MDM2 gene amplification database, Nucleic Acids Res., 26, 3453, 10.1093/nar/26.15.3453 · DOI · Paper page
  62. Momand, 2011, The evolution of MDM2 family genes, Gene, 486, 23, 10.1016/j.gene.2011.06.030 · DOI · Paper page
  63. Momand, 1992, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell, 69, 1237, 10.1016/0092-8674(92)90644-R · DOI · Paper page
  64. Nasevicius, 2000, Effective targeted gene ‘knockdown’ in zebrafish, Nat. Genet., 26, 216, 10.1038/79951 · DOI · Paper page
  65. Nicolas, 2016, Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress, Nat. Commun., 7, 11390, 10.1038/ncomms11390 · DOI · Paper page
  66. Nomoto, 1997, Gene structure of rat BAF60b, a component of mammalian SW1/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene, Gene, 202, 157, 10.1016/S0378-1119(97)00469-1 · DOI
  67. Pant, 2016, Distinct downstream targets manifest p53-dependent pathologies in mice, Oncogene, 35, 5713, 10.1038/onc.2016.111 · DOI
  68. Querido, 2001, Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex, Genes Dev, 15, 3104, 10.1101/gad.926401 · DOI · Paper page
  69. Ramakrishnan, 2014, The ribosome emerges from a black box, Cell, 159, 979, 10.1016/j.cell.2014.10.052 · DOI
  70. Ranaweera, 2013, Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity, J. Biol. Chem., 288, 18939, 10.1074/jbc.M113.454470 · DOI
  71. Sasaki, 2011, Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11, Nat. Med., 17, 944, 10.1038/nm.2392 · DOI · Paper page
  72. Saville, 2004, Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo, J. Biol. Chem., 279, 42169, 10.1074/jbc.M403362200 · DOI · Paper page
  73. Sermeus, 2011, Reciprocal influence of the p53 and the hypoxic pathways, Cell Death Dis., 2, e164, 10.1038/cddis.2011.48 · DOI · Paper page
  74. Siau, 2016, Functional characterization of p53 pathway components in the ancient metazoan Trichoplax adhaerens, Sci. Rep., 6, 33972, 10.1038/srep33972 · DOI · Paper page
  75. Sloan, 2013, The 5 S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress, Cell Rep., 5, 237, 10.1016/j.celrep.2013.08.049 · DOI · Paper page
  76. Snyder, 1988, A gene amplified in a transformed mouse cell line undergoes complex transcriptional processing and encodes a nuclear protein, J. Biol. Chem., 263, 17150, 10.1016/S0021-9258(18)37511-2 · DOI
  77. de Souza, 2010, Diversity and evolution of chromatin proteins encoded by DNA viruses, Biochim. Biophys. Acta, 1799, 302, 10.1016/j.bbagrm.2009.10.006 · DOI
  78. Sui, 2004, Yin Yang 1 is a negative regulator of p53, Cell, 117, 859, 10.1016/j.cell.2004.06.004 · DOI · Paper page
  79. Tan, 2015, Assessing the efficacy of Mdm2/Mdm4-inhibiting stapled peptides using cellular thermal shift assays, Sci. Rep., 5, 12116, 10.1038/srep12116 · DOI
  80. Tashakori, 2016, p53 activity dominates that of p73 upon Mdm4 loss in development and tumorigenesis, Mol. Cancer Res., 14, 56, 10.1158/1541-7786.MCR-15-0346 · DOI
  81. Thisse, 2000, The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis, Differentiation, 66, 61, 10.1046/j.1432-0436.2000.660201.x · DOI
  82. Van de Mark, 2015, MDM1 is a microtubule-binding protein that negatively regulates centriole duplication, Mol. Biol. Cell, 26, 3788, 10.1091/mbc.E15-04-0235 · DOI
  83. Vassilev, 2004, In vivo activation of the p53 pathway by small-molecule antagonists of MDM2, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
  84. Wang, 1996, Diversity and specialization of mammalian SWI/SNF complexes, Genes Dev., 10, 2117, 10.1101/gad.10.17.2117 · DOI · Paper page
  85. Wimmer, 2016, PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53, Oncogene, 35, 69, 10.1038/onc.2015.63 · DOI
  86. Winston, 1992, Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection, Trends Genet., 8, 387, 10.1016/0168-9525(92)90300-S · DOI · Paper page
  87. Wu, 2015, MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function, Oncotarget, 6, 21479, 10.18632/oncotarget.4086 · DOI
  88. Wylie, 2016, p53 genes function to restrain mobile elements, Genes Dev., 30, 64, 10.1101/gad.266098.115 · DOI · Paper page
  89. Zdzalik, 2010, Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73, Cell Cycle, 9, 4584, 10.4161/cc.9.22.13871 · DOI
  90. Zheng, 2015, Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation, Genes Dev., 29, 1524, 10.1101/gad.261792.115 · DOI
  91. Zhou, 2015, Ribosomal proteins: functions beyond the ribosome, J. Mol. Cell Biol., 7, 92, 10.1093/jmcb/mjv014 · DOI · Paper page
  92. Zilfou, 2009, Tumor suppressive functions of p53, Cold Spring Harb. Perspect. Biol., 1, a001883, 10.1101/cshperspect.a001883 · DOI · Paper page

Cited by

See all 35

Metadata

Authors
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R.
Venue
Journal of Molecular Cell Biology
Published
2017-02-01
Volume
9
Issue
1
Pages
3-15
ISSN
1759-4685
Cited by
35
References
34
Language
en
Funders
Agency for Science, Technology and Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.